Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension

K. Swinnen (Leuven, Belgium), M. Delcroix (Leuven, Belgium), R. Quarck (Leuven, Belgium), C. Dewachter (Brussels, Belgium), J. Vachiéry (Brussels, Belgium), C. Belge (Leuven, Belgium)

Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Session: Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Session type: E-poster session
Number: 1521
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Swinnen (Leuven, Belgium), M. Delcroix (Leuven, Belgium), R. Quarck (Leuven, Belgium), C. Dewachter (Brussels, Belgium), J. Vachiéry (Brussels, Belgium), C. Belge (Leuven, Belgium). Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension. 1521

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: